SGLT2 inhibitors and haemoglobin increase: a possible explanation of the cardiovascular benefits?
Home | Video pages | Webcast | Emerging data from EMPA-KIDNEY study
Emerging data from EMPA-KIDNEY study
Disclaimer
The content is not available for HCPs from UK and Ireland